Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
9.72
+0.47 (5.08%)
At close: Mar 31, 2026, 4:00 PM EDT
9.71
-0.01 (-0.10%)
Pre-market: Apr 1, 2026, 7:00 AM EDT
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $523.26 million as of April 1, 2026. Its market cap has decreased by -29.25% in one year.
Market Cap
523.26M
Enterprise Value
224.10M
1-Year Change
-29.25%
Ranking
Category
Stock Price
$9.72
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $523.26M, an increase of 311.04%. That is a compound annual growth rate of 11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 523.30M | 1.79% |
| Dec 31, 2025 | 514.10M | -31.02% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
| Dec 21, 2012 | 127.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 547.19M |
| YD Bio | 541.46M |
| ProKidney | 540.43M |
| CorMedix | 536.75M |
| Kyverna Therapeutics | 521.73M |
| Aclaris Therapeutics | 521.23M |
| AgomAb Therapeutics NV | 511.25M |
| Fulcrum Therapeutics | 510.82M |